6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Purity ≥99.0% Favipiravir Intermediate COVID-19

Katerangan pondok:

Ngaran: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

CAS: 259793-88-9

Purity: ≥99.0%

Panganteur Favipiravir (CAS 259793-96-9) dina pengobatan inféksi virus Influenza sareng COVID-19

Kualitas luhur, Produksi komérsial

Inquiry: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Produsén kalawan Purity High sarta Quality Stabil
Pasokan Komersial Favipiravir sareng Perantara Patali:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Dietil Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Sipat Kimia:

Ngaran Kimia	6-Bromo-3-Hydroxypyrazine-2-Carboxamide
sinonim	Favipiravir panengah;Kotoran Favipiravir 4
Nomer CAS	259793-88-9
Nomer CAT	RF-PI296
Status saham	Dina Stok, Skala Produksi Nepi ka Ratusan Kilogram
Formula Molekul	C5H4BrN3O2
Beurat Molekul	218.01
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Bubuk konéng nepi ka coklat
Idéntifikasi	IR, HPLC
Leungitna dina Drying	≤1,0%
Résidu on Ignition	≤0,20%
Najis Tunggal	≤0,50%
Total Kotoran	≤1,0%
Logam beurat	≤20ppm
Sésa pangleyur	Minuhan spésifikasi
Standar tés	Standar Perusahaan
Pamakéan	Panganteur Favipiravir (CAS 259793-96-9)

Paket & Panyimpenan:

Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.

Kaunggulan:

FAQ:

Aplikasi:

6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) mangrupikeun perantara ilaharna dina sintésis 6-Bromo-3-Hydroxypyrazine-2-Carboxamide sacara komersil ngaranna Favipiravir (CAS 259793-96-9) pengobatan inféksi virus influenza.Rute praktis sareng léngkah-ékonomi pikeun Favipiravir.Favipiravir mangrupikeun produk panalungtikan anu aya hubunganana sareng COVID19, dina pengobatan pasien sareng COVID-19 anu disarankeun ku WHO.Favipiravir, ogé katelah T-705 atanapi Avigan, mangrupikeun ubar antiviral anu dikembangkeun ku Toyama Chemical (Fujifilm Group) Jepang kalayan kagiatan ngalawan seueur virus RNA.Favipiravir disatujuan pikeun pamasaran di Jepang dina Maret 2014 sareng dianggo pikeun pengobatan antiviral influenza A sareng B. Salian virus influenza, ubar ogé nunjukkeun kagiatan antiviral anu hadé pikeun rupa-rupa virus RNA, sapertos virus Ebola, virus pasir, Virus Bunia, virus rabies, jsb. Dina bulan Pebruari 2020 Favipiravir ditalungtik di Cina pikeun pengobatan ékspérimén panyakit COVID-19 (Novel Coronavirus) anu muncul sareng parantos nunjukkeun hasil anu positif.